Animal Model Market Research Report - Forecast till 2027

Animal Model Market Research Report, by Animal Type (Pigs, Cats, and Mice), Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection), Application (Research and Development and Production and Quality Control), End-User (Research Institutes, Educational Institutes, Pharmaceutical Companies, Contract Research Organizations) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast till 2027

ID: MRFR/Pharma/8231-HCR | February 2023 | Region: Global | 140 Pages         

Animal Model Market Speak to Analyst Request a Free Sample

Animal Model Market

Animal Model Market to Grow USD $ 3,632.48 Million With CAGR of 7.8% by 2027

By Animal Type Pigs Cats Mice
By Technology CRISPR Microinjection Embryonic Stem Cell Injection
By Application Research and Development Production Quality Control
By End-User Research Institutes Educational Institutes Pharmaceutical Companies Contract Research Organizations
Key Players
Companies Profiled   Horizon Discovery Group plc   Charles River Laboratories International Inc.   Transposagen Biopharmaceuticals Inc.   Trans Genic Inc   Envigo CRS SA   Eurofins Scientific SE   Crown Bioscience Inc.   The Jackson Laboratory   Genoway SA
Market Driving Forces   Development in CRISPR technology as a powerful tool in the field of biomedical research
Request a Free Sample

Animal Model Market Overview

Animal Model Market size is expected to hold a value of about USD 3,632.48 Million by 2027 and is projected to register a CAGR of 7.8% from 2020 to 2027.

COVID 19 Analysis

One of the major issues that the animal model market functioning is facing during the ongoing forecast period is covering up the losses and leaving the impact of the coronavirus behind. Since the pandemic has hit global boundaries, even the developed nations that have sturdy healthcare facilities and infrastructure are suffering and struggling. The production and manufacturing units of the animal model market have been struggling to meet the vibrant demands but due to the pandemic only, the animal model market has been suffering in terms of the disrupted supply chain mechanism. Also, the lockdown imposed by the global governments during the forecast period of 2020-2027 has been creating a halt in the services and production sector as there is an unavailability of skilled labor and professionals that will help in meeting the expected quality standards of the animal model market. 

During the ongoing forecast period, the global governments have been increasing their support in terms of rolling schemes and regulations followed by investing in global research and development initiatives. Also, collaborations, acquisitions, mergers, and joint ventures are going to help the competitive market players have a great role in the development of the regional and the international market. The market players are likely to develop and launch new products that will help in benefiting the global target audience. 

Market Dynamics


There has been a huge rise in the research and development fields that is one of the major reasons for the growth of the animal model market during the forecast period. The industry experts predict that there will be a huge demand in the requirement for an animal model that helps perform a series of duties related to disease testing and human physiology that will act as major market drivers for the forecast period that will be ending in 2027. 


However, where there are growth opportunities, there will be restraints and challenges, as well. One of the major issues that will restrain the animal model market from growing as per the predicted figures is that the associated cost of study with the market is quite high and there is a stringent regulatory framework that bars the market players to conduct their undertaken and planned operations in a certain and decided way. 

Technology Analysis

There has been a major highlight of the elaborated use of an animal model that is known for its help in areas like validation and target identification. Further, it has a recognized use in areas like safety screening and toxicity, along with drug screening, lead optimization, and preclinical analyses of drug efficacy and safety. The advent of technology along with these factors is likely to promise the market excellent opportunities for growth based on the trends during the forecast period that ends in 2027. Also, there has been a substantial rise in the increase of disorders that are genetics based in various locations across the globe especially during the forecast period that will be ending in 2027. 

Study Objectives

  • To have an idea about the impact of the emergence of the novel coronavirus on the market operations during the post-pandemic period of 2020-2027, and further, discuss the animal model market dynamics like drivers and opportunities that will help in the global development of the animal model market during the ongoing forecast period. Also, to understand the possible restraints and challenges that might restrain the market from growing as per the predictions.

  • To have an idea about the rising competitive degree in the market and draw a competitive graph mentioning all the prominent key players. Further, have a discussion about the potential of the regions and players to emerge as massive competitors during the forecast period in both the regional and the international market.

  • To study the potential of the market segments that are functional in major regions across the globe and understand their ability to meet the rising needs of the target audience. With an enhanced ability, these¬†animal model market segments are likely to help the global market operations reach the predicted market value by the experts and industry leaders.¬†

Segment Overview

The animal model market share is likely to enhance at a good rate during the forecast period of 2020-2027, owing to the splendid performance by the animal model market segments in meeting the needs of the target audience. The animal model market has been segmented based on the following:

By animal type:

The animal type segment of the animal model market includes pets like monkeys, cats, pigs, and mice, amongst others.

By application:

The animal model market deals in a series of applications like academics, research, and development, production, and quality control, like the others.

By the geographical regions:

The rising demand for the market services and products in various global regions is resulting in the development of the market in 4 major regions. The regions are North America, the APAC region, Europe, and the rest of the world (RoW). 

Regional Analysis

Based on the distribution of resources and developing needs of a varied target audience, the animal model market analysis predicts that the global growth is likely to be dominated by the North American region. One of the major reasons that are resulting in this massive growth is the rise in favorable policies that have been introduced by the US and Canadian government is helping in raising various funding plans in the research and development activities. Also, there has been a great rise in the number of investments pouring in, and hence, the animal model market is likely to grow at the maximum rate in this region. 

Competitive Landscape

The rising degree of competition is a result of the increasing research and development followed by investment from various market players. Also, the report aims to draw a competitive comparison amongst the players based on the recent developments undertaken. Theanimal model market players are as follows:

  • Horizon Discovery Group plc

  • Charles River Laboratories International, Inc.

  • Transposagen Biopharmaceuticals, Inc.

  • Trans Genic Inc

  • Envigo CRS SA

  • Eurofins Scientific SE

  • Crown Bioscience, Inc.

  • The Jackson Laboratory

  • Genoway SA¬†

Recent Developments

  • Horizon Discovery Group Plc. is one of the global leaders of the market that is creating a niche for itself in the gene editing and modulation of cell line engineering. On 3rd December 2019, the company came forward to announce that it has entered into a partnership deed with the Human Protein Atlas. Horizon‚Äôs CRISPR-edited knockout cell models were selected to expand the knowledge available with the Cell Atlas Program that is advantageous for understanding the genetic drivers of the prevalent disease.

  • Another collaboration between this company and Mammoth Bioscience was announced with the availability of an additional license agreement. The aim behind this was to access the company‚Äôs platform and facilitate the delivery of a new generation of CHO cells that is responsible for the production of biotherapeutics like antibodies.

  • IGM Biosciences in April 2021 entered into a 2-year long agreement that has a major role in the development of IGMs novel therapeutic IgM antibodies. This will enhance the growth opportunities available for the company.¬†

Intended Audience

  • Market investors and potential buyers

  • Traders, retailers, and manufacturers

  • Exporters and importers

  • Government and Public sector

  • Industry experts¬†

Report Overview

The growth of the animal cell market size is discussed on the market and hence, the report has been curated for an in-depth discussion. The report helps in understanding the global animal model market functioning and hence, discusses the following factors:

  • Market overview

  • COVID 19 Analysis

  • Market Dynamics

  • Technology Analysis

  • Segment Overview

  • Regional Analysis

  • Competitive Landscape

  • Recent Developments¬†

The global report discusses the impact of the pandemic and lockdown on the market operations and further, analyzes the scope of the animal model market based on the segmentation of the animal model market and further, understands the functioning of the market players. Also, the report discusses the ability of the animal model market segments to meet the rising audience needs and potential demand, and also, the efforts of the prominent market players based on the undertaken recent developments during the forecast period that will be ending in 2027.

Report Scope:

Report Attribute/Metric Details
  Market Size   2027: USD 3,632.48 Million
  CAGR   7.8% (2020-2027)
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Animal Type, Technology, Application, End-User, Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Janvier Labs (France), GenOway S.A. (France), Envigo (US), Charles River Laboratories (UK), Taconic Laboratories (UK), Transgenic, Inc. (Japan), SAGE Labs (US), Horizon Discovery (England), Crown Bioscience Inc. (US), Harbor Antibodies Bv (A Subsidiary of Harbor BioMed) (Massachusetts)
  Key Market Opportunities   The increasing innovation and research activity using mice model for immune diseases, cancer, rare disease, and other research activities boost the market growth
  Key Market Drivers

  • Development in CRISPR technology as a powerful tool in the field of biomedical research
  • Growing use of animal models in neurological research, biomedical research, toxicology, genetic research, physiology, cancer research, and xenotransplantation

  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Animal Model Market is projected to hold a substantial value of USD 3,632.48 million by the end of 2027.

    Animal Model Market is expected to thrive at a CAGR of 7.8% by the end of 2027.

    The growing research activity and increasing innovation of mice model for cancer, rare diseases, immune disease, and other R&D activities are likely to propel the global animal model market.

    The global animal model market is estimated to be impeded due to the lack of expertise and strict rules and regulations on the use of animals in research.

    The most established players of the global animal model market are Janvier Labs (France), Harbor Antibodies Bv (A Subsidiary of Harbor BioMed) (Massachusetts), Crown Bioscience Inc. (US), Horizon Discovery (England), SAGE Labs (US), Transgenic, Inc. (Japan), Taconic Laboratories (UK), Charles River Laboratories (UK), Envigo (US), and GenOway S. (France).